Phase 1 Pharmacokinetic Study of Oral Ixazomib Plus Lenalidomide and Dexamethasone in Adult Asian Participants With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT01645930 · COMPLETED
Trial details
- NCT number
- NCT01645930
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-17
- Primary completion
- 2014-07-14
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.